nodes	percent_of_prediction	percent_of_DWPC	metapath
Cimetidine—ABCB1—melanoma	0.132	1	CbGaD
Cimetidine—SLC22A5—Dactinomycin—melanoma	0.111	0.172	CbGbCtD
Cimetidine—SLC22A7—Docetaxel—melanoma	0.0765	0.119	CbGbCtD
Cimetidine—CYP2E1—Dacarbazine—melanoma	0.064	0.0998	CbGbCtD
Cimetidine—CYP1A2—Carmustine—melanoma	0.0611	0.0952	CbGbCtD
Cimetidine—CYP1A2—Vemurafenib—melanoma	0.0483	0.0753	CbGbCtD
Cimetidine—CYP3A4—Temozolomide—melanoma	0.0462	0.072	CbGbCtD
Cimetidine—CYP2D6—Vemurafenib—melanoma	0.0398	0.062	CbGbCtD
Cimetidine—CYP1A2—Dacarbazine—melanoma	0.037	0.0577	CbGbCtD
Cimetidine—CYP3A7—Docetaxel—melanoma	0.0297	0.0463	CbGbCtD
Cimetidine—CYP3A7-CYP3A51P—Docetaxel—melanoma	0.0297	0.0463	CbGbCtD
Cimetidine—ABCB1—Dactinomycin—melanoma	0.0281	0.0437	CbGbCtD
Cimetidine—CYP3A4—Vemurafenib—melanoma	0.0253	0.0394	CbGbCtD
Cimetidine—CYP3A5—Docetaxel—melanoma	0.0223	0.0347	CbGbCtD
Cimetidine—ABCB1—Docetaxel—melanoma	0.0145	0.0226	CbGbCtD
Cimetidine—CYP3A4—Docetaxel—melanoma	0.00868	0.0135	CbGbCtD
Cimetidine—Traumatic liver injury—Temozolomide—melanoma	0.00353	0.0326	CcSEcCtD
Cimetidine—Hepatotoxicity—Vemurafenib—melanoma	0.00334	0.0308	CcSEcCtD
Cimetidine—Musculoskeletal pain—Vemurafenib—melanoma	0.00261	0.0241	CcSEcCtD
Cimetidine—Hepatotoxicity—Dactinomycin—melanoma	0.00188	0.0174	CcSEcCtD
Cimetidine—Hepatotoxicity—Carmustine—melanoma	0.00176	0.0163	CcSEcCtD
Cimetidine—Hepatotoxicity—Temozolomide—melanoma	0.0017	0.0157	CcSEcCtD
Cimetidine—Toxic epidermal necrolysis—Vemurafenib—melanoma	0.00168	0.0155	CcSEcCtD
Cimetidine—Liver injury—Temozolomide—melanoma	0.00156	0.0144	CcSEcCtD
Cimetidine—Stevens-Johnson syndrome—Vemurafenib—melanoma	0.00143	0.0132	CcSEcCtD
Cimetidine—Aplastic anaemia—Dactinomycin—melanoma	0.00137	0.0126	CcSEcCtD
Cimetidine—Musculoskeletal pain—Temozolomide—melanoma	0.00133	0.0123	CcSEcCtD
Cimetidine—Disorientation—Bleomycin—melanoma	0.00127	0.0117	CcSEcCtD
Cimetidine—Aplastic anaemia—Temozolomide—melanoma	0.00124	0.0114	CcSEcCtD
Cimetidine—Erythema multiforme—Vemurafenib—melanoma	0.00122	0.0113	CcSEcCtD
Cimetidine—Gynaecomastia—Carmustine—melanoma	0.00122	0.0112	CcSEcCtD
Cimetidine—Hepatic failure—Dactinomycin—melanoma	0.00118	0.0109	CcSEcCtD
Cimetidine—Alopecia—Vemurafenib—melanoma	0.00114	0.0106	CcSEcCtD
Cimetidine—Hepatotoxicity—Docetaxel—melanoma	0.00113	0.0105	CcSEcCtD
Cimetidine—Hepatic failure—Temozolomide—melanoma	0.00106	0.00981	CcSEcCtD
Cimetidine—Dermatitis exfoliative—Temozolomide—melanoma	0.00101	0.00935	CcSEcCtD
Cimetidine—Arthralgia—Vemurafenib—melanoma	0.000958	0.00885	CcSEcCtD
Cimetidine—Myalgia—Vemurafenib—melanoma	0.000958	0.00885	CcSEcCtD
Cimetidine—Toxic epidermal necrolysis—Dactinomycin—melanoma	0.000951	0.00878	CcSEcCtD
Cimetidine—Pancytopenia—Bleomycin—melanoma	0.00093	0.00858	CcSEcCtD
Cimetidine—Anaphylactic shock—Vemurafenib—melanoma	0.000919	0.00848	CcSEcCtD
Cimetidine—Pneumonia—Bleomycin—melanoma	0.000878	0.0081	CcSEcCtD
Cimetidine—Pancytopenia—Dactinomycin—melanoma	0.000867	0.008	CcSEcCtD
Cimetidine—Toxic epidermal necrolysis—Temozolomide—melanoma	0.00086	0.00794	CcSEcCtD
Cimetidine—Neutropenia—Dactinomycin—melanoma	0.000854	0.00788	CcSEcCtD
Cimetidine—Musculoskeletal discomfort—Vemurafenib—melanoma	0.000837	0.00773	CcSEcCtD
Cimetidine—Pneumonia—Dactinomycin—melanoma	0.000819	0.00756	CcSEcCtD
Cimetidine—Pancytopenia—Carmustine—melanoma	0.000811	0.00749	CcSEcCtD
Cimetidine—Stevens-Johnson syndrome—Dactinomycin—melanoma	0.000807	0.00745	CcSEcCtD
Cimetidine—Neutropenia—Carmustine—melanoma	0.000799	0.00738	CcSEcCtD
Cimetidine—Fatigue—Vemurafenib—melanoma	0.000792	0.00731	CcSEcCtD
Cimetidine—Constipation—Vemurafenib—melanoma	0.000786	0.00725	CcSEcCtD
Cimetidine—Pancytopenia—Temozolomide—melanoma	0.000784	0.00724	CcSEcCtD
Cimetidine—Neutropenia—Temozolomide—melanoma	0.000772	0.00713	CcSEcCtD
Cimetidine—Pneumonia—Carmustine—melanoma	0.000766	0.00707	CcSEcCtD
Cimetidine—Erectile dysfunction—Temozolomide—melanoma	0.00076	0.00702	CcSEcCtD
Cimetidine—Agranulocytosis—Dactinomycin—melanoma	0.00076	0.00701	CcSEcCtD
Cimetidine—Renal failure—Carmustine—melanoma	0.000749	0.00691	CcSEcCtD
Cimetidine—Pneumonia—Temozolomide—melanoma	0.000741	0.00684	CcSEcCtD
Cimetidine—Hepatitis—Dactinomycin—melanoma	0.000731	0.00675	CcSEcCtD
Cimetidine—Stevens-Johnson syndrome—Temozolomide—melanoma	0.00073	0.00674	CcSEcCtD
Cimetidine—Body temperature increased—Vemurafenib—melanoma	0.000726	0.00671	CcSEcCtD
Cimetidine—Hepatic failure—Docetaxel—melanoma	0.000707	0.00653	CcSEcCtD
Cimetidine—Alopecia—Bleomycin—melanoma	0.000692	0.00639	CcSEcCtD
Cimetidine—Erythema multiforme—Dactinomycin—melanoma	0.000691	0.00638	CcSEcCtD
Cimetidine—Hallucination—Carmustine—melanoma	0.00068	0.00628	CcSEcCtD
Cimetidine—Hypersensitivity—Vemurafenib—melanoma	0.000677	0.00625	CcSEcCtD
Cimetidine—Renal impairment—Docetaxel—melanoma	0.000668	0.00616	CcSEcCtD
Cimetidine—Hepatitis—Temozolomide—melanoma	0.000661	0.0061	CcSEcCtD
Cimetidine—Asthenia—Vemurafenib—melanoma	0.000659	0.00609	CcSEcCtD
Cimetidine—Hallucination—Temozolomide—melanoma	0.000658	0.00607	CcSEcCtD
Cimetidine—Alopecia—Dactinomycin—melanoma	0.000646	0.00596	CcSEcCtD
Cimetidine—Diarrhoea—Vemurafenib—melanoma	0.000629	0.0058	CcSEcCtD
Cimetidine—Erythema multiforme—Temozolomide—melanoma	0.000625	0.00577	CcSEcCtD
Cimetidine—Malaise—Bleomycin—melanoma	0.000615	0.00568	CcSEcCtD
Cimetidine—Leukopenia—Bleomycin—melanoma	0.000611	0.00564	CcSEcCtD
Cimetidine—Dizziness—Vemurafenib—melanoma	0.000608	0.00561	CcSEcCtD
Cimetidine—Alopecia—Carmustine—melanoma	0.000604	0.00558	CcSEcCtD
Cimetidine—Vomiting—Vemurafenib—melanoma	0.000584	0.00539	CcSEcCtD
Cimetidine—Alopecia—Temozolomide—melanoma	0.000584	0.00539	CcSEcCtD
Cimetidine—Myalgia—Bleomycin—melanoma	0.000581	0.00536	CcSEcCtD
Cimetidine—Rash—Vemurafenib—melanoma	0.000579	0.00535	CcSEcCtD
Cimetidine—Dermatitis—Vemurafenib—melanoma	0.000579	0.00534	CcSEcCtD
Cimetidine—Headache—Vemurafenib—melanoma	0.000576	0.00531	CcSEcCtD
Cimetidine—Malaise—Dactinomycin—melanoma	0.000574	0.0053	CcSEcCtD
Cimetidine—Toxic epidermal necrolysis—Docetaxel—melanoma	0.000572	0.00528	CcSEcCtD
Cimetidine—Leukopenia—Dactinomycin—melanoma	0.000569	0.00526	CcSEcCtD
Cimetidine—Confusional state—Bleomycin—melanoma	0.000561	0.00518	CcSEcCtD
Cimetidine—Anaphylactic shock—Bleomycin—melanoma	0.000557	0.00514	CcSEcCtD
Cimetidine—Agitation—Carmustine—melanoma	0.000547	0.00505	CcSEcCtD
Cimetidine—Nausea—Vemurafenib—melanoma	0.000546	0.00504	CcSEcCtD
Cimetidine—Thrombocytopenia—Bleomycin—melanoma	0.000545	0.00503	CcSEcCtD
Cimetidine—Myalgia—Dactinomycin—melanoma	0.000542	0.005	CcSEcCtD
Cimetidine—Leukopenia—Carmustine—melanoma	0.000533	0.00492	CcSEcCtD
Cimetidine—Agitation—Temozolomide—melanoma	0.000529	0.00488	CcSEcCtD
Cimetidine—Pancytopenia—Docetaxel—melanoma	0.000521	0.00481	CcSEcCtD
Cimetidine—Malaise—Temozolomide—melanoma	0.000519	0.00479	CcSEcCtD
Cimetidine—Leukopenia—Temozolomide—melanoma	0.000515	0.00475	CcSEcCtD
Cimetidine—Neutropenia—Docetaxel—melanoma	0.000513	0.00474	CcSEcCtD
Cimetidine—Thrombocytopenia—Dactinomycin—melanoma	0.000508	0.00469	CcSEcCtD
Cimetidine—Musculoskeletal discomfort—Bleomycin—melanoma	0.000507	0.00468	CcSEcCtD
Cimetidine—Myalgia—Carmustine—melanoma	0.000507	0.00468	CcSEcCtD
Cimetidine—Anxiety—Carmustine—melanoma	0.000505	0.00466	CcSEcCtD
Cimetidine—Pneumonia—Docetaxel—melanoma	0.000492	0.00455	CcSEcCtD
Cimetidine—Confusional state—Carmustine—melanoma	0.00049	0.00452	CcSEcCtD
Cimetidine—Myalgia—Temozolomide—melanoma	0.00049	0.00452	CcSEcCtD
Cimetidine—Arthralgia—Temozolomide—melanoma	0.00049	0.00452	CcSEcCtD
Cimetidine—Anxiety—Temozolomide—melanoma	0.000488	0.00451	CcSEcCtD
Cimetidine—Stevens-Johnson syndrome—Docetaxel—melanoma	0.000485	0.00448	CcSEcCtD
Cimetidine—Renal failure—Docetaxel—melanoma	0.000481	0.00444	CcSEcCtD
Cimetidine—Thrombocytopenia—Carmustine—melanoma	0.000476	0.00439	CcSEcCtD
Cimetidine—Tachycardia—Carmustine—melanoma	0.000474	0.00438	CcSEcCtD
Cimetidine—Confusional state—Temozolomide—melanoma	0.000473	0.00437	CcSEcCtD
Cimetidine—Musculoskeletal discomfort—Dactinomycin—melanoma	0.000473	0.00437	CcSEcCtD
Cimetidine—Anaphylactic shock—Temozolomide—melanoma	0.00047	0.00434	CcSEcCtD
Cimetidine—Thrombocytopenia—Temozolomide—melanoma	0.00046	0.00424	CcSEcCtD
Cimetidine—Feeling abnormal—Bleomycin—melanoma	0.000459	0.00424	CcSEcCtD
Cimetidine—Agranulocytosis—Docetaxel—melanoma	0.000457	0.00422	CcSEcCtD
Cimetidine—Fatigue—Dactinomycin—melanoma	0.000448	0.00413	CcSEcCtD
Cimetidine—Musculoskeletal discomfort—Carmustine—melanoma	0.000443	0.00409	CcSEcCtD
Cimetidine—Body temperature increased—Bleomycin—melanoma	0.00044	0.00406	CcSEcCtD
Cimetidine—Hepatitis—Docetaxel—melanoma	0.00044	0.00406	CcSEcCtD
Cimetidine—Somnolence—Carmustine—melanoma	0.000432	0.00399	CcSEcCtD
Cimetidine—Feeling abnormal—Dactinomycin—melanoma	0.000428	0.00395	CcSEcCtD
Cimetidine—Musculoskeletal discomfort—Temozolomide—melanoma	0.000428	0.00395	CcSEcCtD
Cimetidine—Somnolence—Temozolomide—melanoma	0.000417	0.00385	CcSEcCtD
Cimetidine—Erythema multiforme—Docetaxel—melanoma	0.000416	0.00384	CcSEcCtD
Cimetidine—Constipation—Carmustine—melanoma	0.000416	0.00384	CcSEcCtD
Cimetidine—Body temperature increased—Dactinomycin—melanoma	0.00041	0.00379	CcSEcCtD
Cimetidine—Hypersensitivity—Bleomycin—melanoma	0.00041	0.00379	CcSEcCtD
Cimetidine—Fatigue—Temozolomide—melanoma	0.000405	0.00374	CcSEcCtD
Cimetidine—Constipation—Temozolomide—melanoma	0.000402	0.00371	CcSEcCtD
Cimetidine—Feeling abnormal—Carmustine—melanoma	0.0004	0.0037	CcSEcCtD
Cimetidine—Asthenia—Bleomycin—melanoma	0.000399	0.00369	CcSEcCtD
Cimetidine—Alopecia—Docetaxel—melanoma	0.000388	0.00359	CcSEcCtD
Cimetidine—Feeling abnormal—Temozolomide—melanoma	0.000387	0.00357	CcSEcCtD
Cimetidine—Body temperature increased—Carmustine—melanoma	0.000384	0.00355	CcSEcCtD
Cimetidine—Hypersensitivity—Dactinomycin—melanoma	0.000382	0.00353	CcSEcCtD
Cimetidine—Asthenia—Dactinomycin—melanoma	0.000372	0.00344	CcSEcCtD
Cimetidine—Body temperature increased—Temozolomide—melanoma	0.000371	0.00343	CcSEcCtD
Cimetidine—Hypersensitivity—Carmustine—melanoma	0.000358	0.00331	CcSEcCtD
Cimetidine—Diarrhoea—Dactinomycin—melanoma	0.000355	0.00328	CcSEcCtD
Cimetidine—Vomiting—Bleomycin—melanoma	0.000354	0.00327	CcSEcCtD
Cimetidine—Rash—Bleomycin—melanoma	0.000351	0.00324	CcSEcCtD
Cimetidine—Dermatitis—Bleomycin—melanoma	0.000351	0.00324	CcSEcCtD
Cimetidine—Asthenia—Carmustine—melanoma	0.000349	0.00322	CcSEcCtD
Cimetidine—Hypersensitivity—Temozolomide—melanoma	0.000346	0.00319	CcSEcCtD
Cimetidine—Leukopenia—Docetaxel—melanoma	0.000342	0.00316	CcSEcCtD
Cimetidine—Asthenia—Temozolomide—melanoma	0.000337	0.00311	CcSEcCtD
Cimetidine—Diarrhoea—Carmustine—melanoma	0.000332	0.00307	CcSEcCtD
Cimetidine—Nausea—Bleomycin—melanoma	0.000331	0.00305	CcSEcCtD
Cimetidine—Vomiting—Dactinomycin—melanoma	0.00033	0.00305	CcSEcCtD
Cimetidine—Rash—Dactinomycin—melanoma	0.000327	0.00302	CcSEcCtD
Cimetidine—Arthralgia—Docetaxel—melanoma	0.000326	0.00301	CcSEcCtD
Cimetidine—Myalgia—Docetaxel—melanoma	0.000326	0.00301	CcSEcCtD
Cimetidine—Dizziness—Carmustine—melanoma	0.000321	0.00297	CcSEcCtD
Cimetidine—Diarrhoea—Temozolomide—melanoma	0.000321	0.00297	CcSEcCtD
Cimetidine—Confusional state—Docetaxel—melanoma	0.000315	0.00291	CcSEcCtD
Cimetidine—Anaphylactic shock—Docetaxel—melanoma	0.000312	0.00288	CcSEcCtD
Cimetidine—Dizziness—Temozolomide—melanoma	0.000311	0.00287	CcSEcCtD
Cimetidine—Vomiting—Carmustine—melanoma	0.000309	0.00285	CcSEcCtD
Cimetidine—Nausea—Dactinomycin—melanoma	0.000308	0.00285	CcSEcCtD
Cimetidine—Rash—Carmustine—melanoma	0.000306	0.00283	CcSEcCtD
Cimetidine—Dermatitis—Carmustine—melanoma	0.000306	0.00283	CcSEcCtD
Cimetidine—Thrombocytopenia—Docetaxel—melanoma	0.000306	0.00282	CcSEcCtD
Cimetidine—Tachycardia—Docetaxel—melanoma	0.000305	0.00281	CcSEcCtD
Cimetidine—Headache—Carmustine—melanoma	0.000304	0.00281	CcSEcCtD
Cimetidine—Vomiting—Temozolomide—melanoma	0.000299	0.00276	CcSEcCtD
Cimetidine—Rash—Temozolomide—melanoma	0.000296	0.00273	CcSEcCtD
Cimetidine—Dermatitis—Temozolomide—melanoma	0.000296	0.00273	CcSEcCtD
Cimetidine—Headache—Temozolomide—melanoma	0.000294	0.00272	CcSEcCtD
Cimetidine—Nausea—Carmustine—melanoma	0.000289	0.00266	CcSEcCtD
Cimetidine—Musculoskeletal discomfort—Docetaxel—melanoma	0.000284	0.00263	CcSEcCtD
Cimetidine—Nausea—Temozolomide—melanoma	0.000279	0.00258	CcSEcCtD
Cimetidine—Somnolence—Docetaxel—melanoma	0.000278	0.00256	CcSEcCtD
Cimetidine—Fatigue—Docetaxel—melanoma	0.000269	0.00249	CcSEcCtD
Cimetidine—Constipation—Docetaxel—melanoma	0.000267	0.00247	CcSEcCtD
Cimetidine—Feeling abnormal—Docetaxel—melanoma	0.000257	0.00238	CcSEcCtD
Cimetidine—Body temperature increased—Docetaxel—melanoma	0.000247	0.00228	CcSEcCtD
Cimetidine—Hypersensitivity—Docetaxel—melanoma	0.00023	0.00212	CcSEcCtD
Cimetidine—Asthenia—Docetaxel—melanoma	0.000224	0.00207	CcSEcCtD
Cimetidine—Diarrhoea—Docetaxel—melanoma	0.000214	0.00197	CcSEcCtD
Cimetidine—Dizziness—Docetaxel—melanoma	0.000206	0.00191	CcSEcCtD
Cimetidine—Vomiting—Docetaxel—melanoma	0.000199	0.00183	CcSEcCtD
Cimetidine—Rash—Docetaxel—melanoma	0.000197	0.00182	CcSEcCtD
Cimetidine—Dermatitis—Docetaxel—melanoma	0.000197	0.00182	CcSEcCtD
Cimetidine—Headache—Docetaxel—melanoma	0.000196	0.00181	CcSEcCtD
Cimetidine—Nausea—Docetaxel—melanoma	0.000185	0.00171	CcSEcCtD
Cimetidine—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—melanoma	8.56e-06	7.28e-05	CbGpPWpGaD
Cimetidine—CYP2C19—Metabolism—CYP17A1—melanoma	8.55e-06	7.27e-05	CbGpPWpGaD
Cimetidine—CYP3A4—Metabolism—CUBN—melanoma	8.53e-06	7.26e-05	CbGpPWpGaD
Cimetidine—CYP2C9—Metabolism of lipids and lipoproteins—PPARG—melanoma	8.44e-06	7.18e-05	CbGpPWpGaD
Cimetidine—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CD—melanoma	8.43e-06	7.17e-05	CbGpPWpGaD
Cimetidine—CYP2C8—Metabolism—GNAQ—melanoma	8.41e-06	7.15e-05	CbGpPWpGaD
Cimetidine—CYP2C8—Metabolism—CD44—melanoma	8.41e-06	7.15e-05	CbGpPWpGaD
Cimetidine—ABCB1—Metabolism—CYP17A1—melanoma	8.34e-06	7.1e-05	CbGpPWpGaD
Cimetidine—CYP2C19—Metabolism of lipids and lipoproteins—ALB—melanoma	8.32e-06	7.08e-05	CbGpPWpGaD
Cimetidine—HRH2—Signaling Pathways—CXCL8—melanoma	8.32e-06	7.08e-05	CbGpPWpGaD
Cimetidine—HRH2—Signaling by GPCR—HRAS—melanoma	8.27e-06	7.03e-05	CbGpPWpGaD
Cimetidine—CYP3A4—Metabolism—SDHD—melanoma	8.24e-06	7.01e-05	CbGpPWpGaD
Cimetidine—CYP3A4—Metabolism—CSPG4—melanoma	8.24e-06	7.01e-05	CbGpPWpGaD
Cimetidine—CYP3A4—Metabolism—BSG—melanoma	8.24e-06	7.01e-05	CbGpPWpGaD
Cimetidine—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CB—melanoma	8.23e-06	7e-05	CbGpPWpGaD
Cimetidine—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—melanoma	8.16e-06	6.94e-05	CbGpPWpGaD
Cimetidine—HRH2—Signaling Pathways—CDKN1B—melanoma	8.12e-06	6.91e-05	CbGpPWpGaD
Cimetidine—CYP2C19—Metabolism—GNA11—melanoma	8.07e-06	6.87e-05	CbGpPWpGaD
Cimetidine—CYP2C8—Metabolism—CYP1B1—melanoma	8.06e-06	6.86e-05	CbGpPWpGaD
Cimetidine—SLC22A3—Metabolism—PTEN—melanoma	8.06e-06	6.85e-05	CbGpPWpGaD
Cimetidine—HRH2—GPCR downstream signaling—AKT1—melanoma	8.04e-06	6.84e-05	CbGpPWpGaD
Cimetidine—CYP3A4—Metabolism—GPAM—melanoma	7.98e-06	6.79e-05	CbGpPWpGaD
Cimetidine—HRH2—Signaling Pathways—CASP3—melanoma	7.96e-06	6.77e-05	CbGpPWpGaD
Cimetidine—HRH2—Signaling Pathways—IL2—melanoma	7.95e-06	6.76e-05	CbGpPWpGaD
Cimetidine—HRH2—Signaling by GPCR—IL6—melanoma	7.91e-06	6.73e-05	CbGpPWpGaD
Cimetidine—CYP2C19—Metabolism—FASN—melanoma	7.9e-06	6.72e-05	CbGpPWpGaD
Cimetidine—CYP1A2—Metabolism—VCAN—melanoma	7.9e-06	6.72e-05	CbGpPWpGaD
Cimetidine—ABCB1—Metabolism—GNA11—melanoma	7.88e-06	6.7e-05	CbGpPWpGaD
Cimetidine—CYP2D6—Metabolism—CYP17A1—melanoma	7.86e-06	6.69e-05	CbGpPWpGaD
Cimetidine—CYP2C9—Metabolism—CYP17A1—melanoma	7.8e-06	6.63e-05	CbGpPWpGaD
Cimetidine—CYP2C19—Metabolism—SLC5A5—melanoma	7.77e-06	6.61e-05	CbGpPWpGaD
Cimetidine—HRH2—Signaling Pathways—CCND1—melanoma	7.75e-06	6.59e-05	CbGpPWpGaD
Cimetidine—ABCB1—Transmembrane transport of small molecules—ALB—melanoma	7.73e-06	6.57e-05	CbGpPWpGaD
Cimetidine—ABCB11—Metabolism—PTEN—melanoma	7.72e-06	6.57e-05	CbGpPWpGaD
Cimetidine—ABCB1—Metabolism—FASN—melanoma	7.71e-06	6.56e-05	CbGpPWpGaD
Cimetidine—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CD—melanoma	7.69e-06	6.54e-05	CbGpPWpGaD
Cimetidine—CYP2E1—Metabolism—ABCB1—melanoma	7.68e-06	6.53e-05	CbGpPWpGaD
Cimetidine—HRH2—Signaling Pathways—CTNNB1—melanoma	7.68e-06	6.53e-05	CbGpPWpGaD
Cimetidine—CYP3A5—Metabolism—ABCB1—melanoma	7.66e-06	6.52e-05	CbGpPWpGaD
Cimetidine—CYP3A7—Metabolism—PIK3CG—melanoma	7.64e-06	6.5e-05	CbGpPWpGaD
Cimetidine—SLC22A2—Metabolism—PIK3CG—melanoma	7.63e-06	6.49e-05	CbGpPWpGaD
Cimetidine—CYP2C9—Metabolism of lipids and lipoproteins—ALB—melanoma	7.59e-06	6.46e-05	CbGpPWpGaD
Cimetidine—ABCB1—Metabolism—SLC5A5—melanoma	7.59e-06	6.45e-05	CbGpPWpGaD
Cimetidine—HRH2—Signaling Pathways—MMP9—melanoma	7.53e-06	6.4e-05	CbGpPWpGaD
Cimetidine—CYP2C19—Metabolism—CD44—melanoma	7.51e-06	6.39e-05	CbGpPWpGaD
Cimetidine—CYP2C19—Metabolism—GNAQ—melanoma	7.51e-06	6.39e-05	CbGpPWpGaD
Cimetidine—HRH2—Signaling Pathways—CDKN1A—melanoma	7.5e-06	6.38e-05	CbGpPWpGaD
Cimetidine—HRH2—Signaling Pathways—PTEN—melanoma	7.48e-06	6.36e-05	CbGpPWpGaD
Cimetidine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CG—melanoma	7.47e-06	6.36e-05	CbGpPWpGaD
Cimetidine—HRH2—Signaling Pathways—NFKB1—melanoma	7.45e-06	6.33e-05	CbGpPWpGaD
Cimetidine—CYP2D6—Metabolism—GNA11—melanoma	7.43e-06	6.32e-05	CbGpPWpGaD
Cimetidine—CYP3A7—Metabolism—PPARG—melanoma	7.38e-06	6.28e-05	CbGpPWpGaD
Cimetidine—SLC22A2—Metabolism—PPARG—melanoma	7.37e-06	6.27e-05	CbGpPWpGaD
Cimetidine—CYP2C9—Metabolism—GNA11—melanoma	7.36e-06	6.26e-05	CbGpPWpGaD
Cimetidine—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CB—melanoma	7.35e-06	6.25e-05	CbGpPWpGaD
Cimetidine—ABCB1—Metabolism—GNAQ—melanoma	7.33e-06	6.23e-05	CbGpPWpGaD
Cimetidine—ABCB1—Metabolism—CD44—melanoma	7.33e-06	6.23e-05	CbGpPWpGaD
Cimetidine—HRH2—Signaling by GPCR—AKT1—melanoma	7.3e-06	6.21e-05	CbGpPWpGaD
Cimetidine—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—melanoma	7.28e-06	6.2e-05	CbGpPWpGaD
Cimetidine—CYP2D6—Metabolism—FASN—melanoma	7.27e-06	6.18e-05	CbGpPWpGaD
Cimetidine—CYP11B1—Metabolism—PIK3CA—melanoma	7.26e-06	6.17e-05	CbGpPWpGaD
Cimetidine—CYP1A2—Metabolism of lipids and lipoproteins—PPARG—melanoma	7.21e-06	6.14e-05	CbGpPWpGaD
Cimetidine—FMO3—Metabolism—AKT1—melanoma	7.21e-06	6.13e-05	CbGpPWpGaD
Cimetidine—CYP2C9—Metabolism—FASN—melanoma	7.2e-06	6.13e-05	CbGpPWpGaD
Cimetidine—CYP2C19—Metabolism—CYP1B1—melanoma	7.2e-06	6.12e-05	CbGpPWpGaD
Cimetidine—CYP2D6—Metabolism—SLC5A5—melanoma	7.15e-06	6.08e-05	CbGpPWpGaD
Cimetidine—CYP2C8—Metabolism of lipids and lipoproteins—PTEN—melanoma	7.12e-06	6.05e-05	CbGpPWpGaD
Cimetidine—SLC22A1—Metabolism—PIK3CG—melanoma	7.11e-06	6.05e-05	CbGpPWpGaD
Cimetidine—CYP2C9—Metabolism—SLC5A5—melanoma	7.09e-06	6.03e-05	CbGpPWpGaD
Cimetidine—CYP2E1—Metabolism—PRKCA—melanoma	7.07e-06	6.01e-05	CbGpPWpGaD
Cimetidine—CYP3A5—Metabolism—PRKCA—melanoma	7.05e-06	6e-05	CbGpPWpGaD
Cimetidine—ABCB1—Metabolism—CYP1B1—melanoma	7.02e-06	5.98e-05	CbGpPWpGaD
Cimetidine—CYP2E1—Metabolism—ERCC2—melanoma	7.01e-06	5.96e-05	CbGpPWpGaD
Cimetidine—CYP3A5—Metabolism—ERCC2—melanoma	7e-06	5.95e-05	CbGpPWpGaD
Cimetidine—CYP2D6—Metabolism—GNAQ—melanoma	6.9e-06	5.87e-05	CbGpPWpGaD
Cimetidine—CYP2D6—Metabolism—CD44—melanoma	6.9e-06	5.87e-05	CbGpPWpGaD
Cimetidine—SLC22A1—Metabolism—PPARG—melanoma	6.87e-06	5.84e-05	CbGpPWpGaD
Cimetidine—CYP2C9—Metabolism—CD44—melanoma	6.84e-06	5.82e-05	CbGpPWpGaD
Cimetidine—CYP2C9—Metabolism—GNAQ—melanoma	6.84e-06	5.82e-05	CbGpPWpGaD
Cimetidine—CYP3A4—Metabolism—PLA2G6—melanoma	6.78e-06	5.77e-05	CbGpPWpGaD
Cimetidine—HRH2—Signaling Pathways—VEGFA—melanoma	6.76e-06	5.75e-05	CbGpPWpGaD
Cimetidine—CYP3A7—Metabolism—PIK3CD—melanoma	6.72e-06	5.72e-05	CbGpPWpGaD
Cimetidine—SLC22A2—Metabolism—PIK3CD—melanoma	6.71e-06	5.71e-05	CbGpPWpGaD
Cimetidine—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CB—melanoma	6.7e-06	5.7e-05	CbGpPWpGaD
Cimetidine—HRH2—Signaling Pathways—STAT3—melanoma	6.69e-06	5.69e-05	CbGpPWpGaD
Cimetidine—HRH2—Signaling Pathways—NRAS—melanoma	6.67e-06	5.68e-05	CbGpPWpGaD
Cimetidine—CYP1A2—Metabolism—CYP17A1—melanoma	6.66e-06	5.67e-05	CbGpPWpGaD
Cimetidine—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—melanoma	6.64e-06	5.65e-05	CbGpPWpGaD
Cimetidine—CYP2C8—Metabolism—ABCB1—melanoma	6.64e-06	5.65e-05	CbGpPWpGaD
Cimetidine—CYP3A7—Metabolism—ALB—melanoma	6.63e-06	5.64e-05	CbGpPWpGaD
Cimetidine—SLC22A2—Metabolism—ALB—melanoma	6.62e-06	5.63e-05	CbGpPWpGaD
Cimetidine—CYP2D6—Metabolism—CYP1B1—melanoma	6.62e-06	5.63e-05	CbGpPWpGaD
Cimetidine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CD—melanoma	6.57e-06	5.59e-05	CbGpPWpGaD
Cimetidine—CYP2C9—Metabolism—CYP1B1—melanoma	6.56e-06	5.58e-05	CbGpPWpGaD
Cimetidine—CYP1A2—Metabolism of lipids and lipoproteins—ALB—melanoma	6.49e-06	5.52e-05	CbGpPWpGaD
Cimetidine—HRH2—Signaling Pathways—MAPK3—melanoma	6.39e-06	5.44e-05	CbGpPWpGaD
Cimetidine—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—melanoma	6.35e-06	5.4e-05	CbGpPWpGaD
Cimetidine—CYP1A2—Metabolism—GNA11—melanoma	6.29e-06	5.35e-05	CbGpPWpGaD
Cimetidine—SLC22A1—Metabolism—PIK3CD—melanoma	6.25e-06	5.32e-05	CbGpPWpGaD
Cimetidine—HRH2—Signaling Pathways—MYC—melanoma	6.22e-06	5.29e-05	CbGpPWpGaD
Cimetidine—SLC22A1—Metabolism—ALB—melanoma	6.17e-06	5.25e-05	CbGpPWpGaD
Cimetidine—CYP1A2—Metabolism—FASN—melanoma	6.16e-06	5.24e-05	CbGpPWpGaD
Cimetidine—CYP2C8—Metabolism—PRKCA—melanoma	6.11e-06	5.2e-05	CbGpPWpGaD
Cimetidine—CYP3A4—Metabolism—VCAN—melanoma	6.09e-06	5.18e-05	CbGpPWpGaD
Cimetidine—HRH2—Signaling Pathways—MAPK1—melanoma	6.08e-06	5.17e-05	CbGpPWpGaD
Cimetidine—HRH2—Signaling Pathways—EGFR—melanoma	6.08e-06	5.17e-05	CbGpPWpGaD
Cimetidine—CYP2C8—Metabolism—ERCC2—melanoma	6.06e-06	5.16e-05	CbGpPWpGaD
Cimetidine—CYP1A2—Metabolism—SLC5A5—melanoma	6.06e-06	5.15e-05	CbGpPWpGaD
Cimetidine—CYP11B1—Metabolism—AKT1—melanoma	5.93e-06	5.04e-05	CbGpPWpGaD
Cimetidine—CYP2C19—Metabolism—ABCB1—melanoma	5.93e-06	5.04e-05	CbGpPWpGaD
Cimetidine—CYP3A7—Metabolism—PIK3CB—melanoma	5.86e-06	4.98e-05	CbGpPWpGaD
Cimetidine—CYP1A2—Metabolism—GNAQ—melanoma	5.85e-06	4.98e-05	CbGpPWpGaD
Cimetidine—CYP1A2—Metabolism—CD44—melanoma	5.85e-06	4.98e-05	CbGpPWpGaD
Cimetidine—SLC22A2—Metabolism—PIK3CB—melanoma	5.85e-06	4.97e-05	CbGpPWpGaD
Cimetidine—CYP3A7—Metabolism—PTGS2—melanoma	5.8e-06	4.94e-05	CbGpPWpGaD
Cimetidine—SLC22A2—Metabolism—PTGS2—melanoma	5.79e-06	4.93e-05	CbGpPWpGaD
Cimetidine—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—melanoma	5.79e-06	4.93e-05	CbGpPWpGaD
Cimetidine—HRH2—Signaling Pathways—KRAS—melanoma	5.74e-06	4.89e-05	CbGpPWpGaD
Cimetidine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CB—melanoma	5.73e-06	4.87e-05	CbGpPWpGaD
Cimetidine—SLC22A3—Metabolism—PIK3CA—melanoma	5.68e-06	4.84e-05	CbGpPWpGaD
Cimetidine—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—melanoma	5.67e-06	4.83e-05	CbGpPWpGaD
Cimetidine—CYP1A2—Metabolism—CYP1B1—melanoma	5.61e-06	4.77e-05	CbGpPWpGaD
Cimetidine—CYP2E1—Metabolism—PIK3CG—melanoma	5.54e-06	4.71e-05	CbGpPWpGaD
Cimetidine—CYP3A5—Metabolism—PIK3CG—melanoma	5.53e-06	4.7e-05	CbGpPWpGaD
Cimetidine—CYP2C19—Metabolism—PRKCA—melanoma	5.45e-06	4.64e-05	CbGpPWpGaD
Cimetidine—SLC22A1—Metabolism—PIK3CB—melanoma	5.45e-06	4.64e-05	CbGpPWpGaD
Cimetidine—CYP2D6—Metabolism—ABCB1—melanoma	5.45e-06	4.64e-05	CbGpPWpGaD
Cimetidine—ABCB11—Metabolism—PIK3CA—melanoma	5.45e-06	4.64e-05	CbGpPWpGaD
Cimetidine—CYP2C19—Metabolism—ERCC2—melanoma	5.41e-06	4.6e-05	CbGpPWpGaD
Cimetidine—CYP2C9—Metabolism—ABCB1—melanoma	5.4e-06	4.6e-05	CbGpPWpGaD
Cimetidine—SLC22A1—Metabolism—PTGS2—melanoma	5.4e-06	4.59e-05	CbGpPWpGaD
Cimetidine—CYP2E1—Metabolism—PPARG—melanoma	5.34e-06	4.55e-05	CbGpPWpGaD
Cimetidine—CYP3A5—Metabolism—PPARG—melanoma	5.33e-06	4.54e-05	CbGpPWpGaD
Cimetidine—ABCB1—Metabolism—PRKCA—melanoma	5.32e-06	4.53e-05	CbGpPWpGaD
Cimetidine—ABCB1—Metabolism—ERCC2—melanoma	5.28e-06	4.49e-05	CbGpPWpGaD
Cimetidine—HRH2—Signaling Pathways—PIK3CA—melanoma	5.28e-06	4.49e-05	CbGpPWpGaD
Cimetidine—CYP3A4—Metabolism—CYP17A1—melanoma	5.14e-06	4.37e-05	CbGpPWpGaD
Cimetidine—HRH2—Signaling Pathways—TP53—melanoma	5.11e-06	4.34e-05	CbGpPWpGaD
Cimetidine—CYP3A7—Metabolism—PTEN—melanoma	5.06e-06	4.31e-05	CbGpPWpGaD
Cimetidine—SLC22A2—Metabolism—PTEN—melanoma	5.05e-06	4.3e-05	CbGpPWpGaD
Cimetidine—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—melanoma	5.02e-06	4.27e-05	CbGpPWpGaD
Cimetidine—CYP2D6—Metabolism—PRKCA—melanoma	5.02e-06	4.27e-05	CbGpPWpGaD
Cimetidine—CYP2D6—Metabolism—ERCC2—melanoma	4.97e-06	4.23e-05	CbGpPWpGaD
Cimetidine—CYP2C9—Metabolism—PRKCA—melanoma	4.97e-06	4.23e-05	CbGpPWpGaD
Cimetidine—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—melanoma	4.95e-06	4.21e-05	CbGpPWpGaD
Cimetidine—CYP2C9—Metabolism—ERCC2—melanoma	4.93e-06	4.2e-05	CbGpPWpGaD
Cimetidine—HRH2—Signaling Pathways—HRAS—melanoma	4.88e-06	4.15e-05	CbGpPWpGaD
Cimetidine—CYP2E1—Metabolism—PIK3CD—melanoma	4.87e-06	4.14e-05	CbGpPWpGaD
Cimetidine—CYP3A5—Metabolism—PIK3CD—melanoma	4.86e-06	4.13e-05	CbGpPWpGaD
Cimetidine—CYP3A4—Metabolism—GNA11—melanoma	4.86e-06	4.13e-05	CbGpPWpGaD
Cimetidine—CYP2E1—Metabolism—ALB—melanoma	4.8e-06	4.09e-05	CbGpPWpGaD
Cimetidine—CYP3A5—Metabolism—ALB—melanoma	4.8e-06	4.08e-05	CbGpPWpGaD
Cimetidine—CYP2C8—Metabolism—PIK3CG—melanoma	4.79e-06	4.07e-05	CbGpPWpGaD
Cimetidine—CYP3A4—Metabolism—FASN—melanoma	4.75e-06	4.04e-05	CbGpPWpGaD
Cimetidine—SLC22A1—Metabolism—PTEN—melanoma	4.71e-06	4.01e-05	CbGpPWpGaD
Cimetidine—HRH2—Signaling Pathways—IL6—melanoma	4.67e-06	3.98e-05	CbGpPWpGaD
Cimetidine—CYP3A4—Metabolism—SLC5A5—melanoma	4.67e-06	3.98e-05	CbGpPWpGaD
Cimetidine—SLC22A3—Metabolism—AKT1—melanoma	4.64e-06	3.95e-05	CbGpPWpGaD
Cimetidine—CYP2C8—Metabolism—PPARG—melanoma	4.62e-06	3.93e-05	CbGpPWpGaD
Cimetidine—CYP1A2—Metabolism—ABCB1—melanoma	4.62e-06	3.93e-05	CbGpPWpGaD
Cimetidine—CYP3A4—Metabolism—GNAQ—melanoma	4.51e-06	3.84e-05	CbGpPWpGaD
Cimetidine—CYP3A4—Metabolism—CD44—melanoma	4.51e-06	3.84e-05	CbGpPWpGaD
Cimetidine—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—melanoma	4.48e-06	3.81e-05	CbGpPWpGaD
Cimetidine—ABCB11—Metabolism—AKT1—melanoma	4.45e-06	3.79e-05	CbGpPWpGaD
Cimetidine—CYP3A4—Metabolism—CYP1B1—melanoma	4.33e-06	3.68e-05	CbGpPWpGaD
Cimetidine—HRH2—Signaling Pathways—AKT1—melanoma	4.31e-06	3.67e-05	CbGpPWpGaD
Cimetidine—CYP2C19—Metabolism—PIK3CG—melanoma	4.27e-06	3.63e-05	CbGpPWpGaD
Cimetidine—CYP1A2—Metabolism—PRKCA—melanoma	4.25e-06	3.61e-05	CbGpPWpGaD
Cimetidine—CYP2E1—Metabolism—PIK3CB—melanoma	4.24e-06	3.61e-05	CbGpPWpGaD
Cimetidine—CYP3A5—Metabolism—PIK3CB—melanoma	4.23e-06	3.6e-05	CbGpPWpGaD
Cimetidine—CYP1A2—Metabolism—ERCC2—melanoma	4.21e-06	3.59e-05	CbGpPWpGaD
Cimetidine—CYP2C8—Metabolism—PIK3CD—melanoma	4.21e-06	3.58e-05	CbGpPWpGaD
Cimetidine—CYP2E1—Metabolism—PTGS2—melanoma	4.2e-06	3.58e-05	CbGpPWpGaD
Cimetidine—CYP3A5—Metabolism—PTGS2—melanoma	4.19e-06	3.57e-05	CbGpPWpGaD
Cimetidine—ABCB1—Metabolism—PIK3CG—melanoma	4.17e-06	3.55e-05	CbGpPWpGaD
Cimetidine—CYP2C8—Metabolism—ALB—melanoma	4.15e-06	3.53e-05	CbGpPWpGaD
Cimetidine—CYP2C19—Metabolism—PPARG—melanoma	4.12e-06	3.51e-05	CbGpPWpGaD
Cimetidine—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—melanoma	4.09e-06	3.48e-05	CbGpPWpGaD
Cimetidine—ABCB1—Metabolism—PPARG—melanoma	4.02e-06	3.42e-05	CbGpPWpGaD
Cimetidine—CYP2D6—Metabolism—PIK3CG—melanoma	3.93e-06	3.34e-05	CbGpPWpGaD
Cimetidine—CYP2C9—Metabolism—PIK3CG—melanoma	3.89e-06	3.31e-05	CbGpPWpGaD
Cimetidine—CYP2D6—Metabolism—PPARG—melanoma	3.79e-06	3.23e-05	CbGpPWpGaD
Cimetidine—CYP2C9—Metabolism—PPARG—melanoma	3.76e-06	3.2e-05	CbGpPWpGaD
Cimetidine—CYP2C19—Metabolism—PIK3CD—melanoma	3.76e-06	3.19e-05	CbGpPWpGaD
Cimetidine—CYP2C19—Metabolism—ALB—melanoma	3.71e-06	3.15e-05	CbGpPWpGaD
Cimetidine—CYP2C8—Metabolism—PIK3CB—melanoma	3.67e-06	3.12e-05	CbGpPWpGaD
Cimetidine—CYP2E1—Metabolism—PTEN—melanoma	3.67e-06	3.12e-05	CbGpPWpGaD
Cimetidine—ABCB1—Metabolism—PIK3CD—melanoma	3.67e-06	3.12e-05	CbGpPWpGaD
Cimetidine—CYP3A5—Metabolism—PTEN—melanoma	3.66e-06	3.11e-05	CbGpPWpGaD
Cimetidine—CYP2C8—Metabolism—PTGS2—melanoma	3.63e-06	3.09e-05	CbGpPWpGaD
Cimetidine—ABCB1—Metabolism—ALB—melanoma	3.62e-06	3.08e-05	CbGpPWpGaD
Cimetidine—CYP3A7—Metabolism—PIK3CA—melanoma	3.57e-06	3.04e-05	CbGpPWpGaD
Cimetidine—SLC22A2—Metabolism—PIK3CA—melanoma	3.56e-06	3.03e-05	CbGpPWpGaD
Cimetidine—CYP3A4—Metabolism—ABCB1—melanoma	3.56e-06	3.03e-05	CbGpPWpGaD
Cimetidine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—melanoma	3.49e-06	2.97e-05	CbGpPWpGaD
Cimetidine—CYP2D6—Metabolism—PIK3CD—melanoma	3.45e-06	2.94e-05	CbGpPWpGaD
Cimetidine—CYP2C9—Metabolism—PIK3CD—melanoma	3.42e-06	2.91e-05	CbGpPWpGaD
Cimetidine—CYP2D6—Metabolism—ALB—melanoma	3.41e-06	2.9e-05	CbGpPWpGaD
Cimetidine—CYP2C9—Metabolism—ALB—melanoma	3.38e-06	2.88e-05	CbGpPWpGaD
Cimetidine—CYP1A2—Metabolism—PIK3CG—melanoma	3.33e-06	2.83e-05	CbGpPWpGaD
Cimetidine—SLC22A1—Metabolism—PIK3CA—melanoma	3.32e-06	2.83e-05	CbGpPWpGaD
Cimetidine—CYP3A4—Metabolism—PRKCA—melanoma	3.28e-06	2.79e-05	CbGpPWpGaD
Cimetidine—CYP2C19—Metabolism—PIK3CB—melanoma	3.27e-06	2.78e-05	CbGpPWpGaD
Cimetidine—CYP3A4—Metabolism—ERCC2—melanoma	3.25e-06	2.77e-05	CbGpPWpGaD
Cimetidine—CYP2C19—Metabolism—PTGS2—melanoma	3.24e-06	2.76e-05	CbGpPWpGaD
Cimetidine—CYP1A2—Metabolism—PPARG—melanoma	3.21e-06	2.73e-05	CbGpPWpGaD
Cimetidine—ABCB1—Metabolism—PIK3CB—melanoma	3.19e-06	2.72e-05	CbGpPWpGaD
Cimetidine—CYP2C8—Metabolism—PTEN—melanoma	3.17e-06	2.7e-05	CbGpPWpGaD
Cimetidine—ABCB1—Metabolism—PTGS2—melanoma	3.17e-06	2.69e-05	CbGpPWpGaD
Cimetidine—CYP2D6—Metabolism—PIK3CB—melanoma	3.01e-06	2.56e-05	CbGpPWpGaD
Cimetidine—CYP2C9—Metabolism—PIK3CB—melanoma	2.98e-06	2.54e-05	CbGpPWpGaD
Cimetidine—CYP2D6—Metabolism—PTGS2—melanoma	2.98e-06	2.54e-05	CbGpPWpGaD
Cimetidine—CYP2C9—Metabolism—PTGS2—melanoma	2.96e-06	2.52e-05	CbGpPWpGaD
Cimetidine—CYP1A2—Metabolism—PIK3CD—melanoma	2.93e-06	2.49e-05	CbGpPWpGaD
Cimetidine—CYP3A7—Metabolism—AKT1—melanoma	2.92e-06	2.48e-05	CbGpPWpGaD
Cimetidine—SLC22A2—Metabolism—AKT1—melanoma	2.91e-06	2.48e-05	CbGpPWpGaD
Cimetidine—CYP1A2—Metabolism—ALB—melanoma	2.89e-06	2.46e-05	CbGpPWpGaD
Cimetidine—CYP2C19—Metabolism—PTEN—melanoma	2.83e-06	2.41e-05	CbGpPWpGaD
Cimetidine—ABCB1—Metabolism—PTEN—melanoma	2.76e-06	2.35e-05	CbGpPWpGaD
Cimetidine—SLC22A1—Metabolism—AKT1—melanoma	2.71e-06	2.31e-05	CbGpPWpGaD
Cimetidine—CYP2D6—Metabolism—PTEN—melanoma	2.6e-06	2.21e-05	CbGpPWpGaD
Cimetidine—CYP2E1—Metabolism—PIK3CA—melanoma	2.59e-06	2.2e-05	CbGpPWpGaD
Cimetidine—CYP3A5—Metabolism—PIK3CA—melanoma	2.58e-06	2.2e-05	CbGpPWpGaD
Cimetidine—CYP2C9—Metabolism—PTEN—melanoma	2.58e-06	2.19e-05	CbGpPWpGaD
Cimetidine—CYP3A4—Metabolism—PIK3CG—melanoma	2.57e-06	2.19e-05	CbGpPWpGaD
Cimetidine—CYP1A2—Metabolism—PIK3CB—melanoma	2.55e-06	2.17e-05	CbGpPWpGaD
Cimetidine—CYP1A2—Metabolism—PTGS2—melanoma	2.53e-06	2.15e-05	CbGpPWpGaD
Cimetidine—CYP3A4—Metabolism—PPARG—melanoma	2.48e-06	2.11e-05	CbGpPWpGaD
Cimetidine—CYP3A4—Metabolism—PIK3CD—melanoma	2.26e-06	1.92e-05	CbGpPWpGaD
Cimetidine—CYP2C8—Metabolism—PIK3CA—melanoma	2.24e-06	1.9e-05	CbGpPWpGaD
Cimetidine—CYP3A4—Metabolism—ALB—melanoma	2.23e-06	1.9e-05	CbGpPWpGaD
Cimetidine—CYP1A2—Metabolism—PTEN—melanoma	2.2e-06	1.87e-05	CbGpPWpGaD
Cimetidine—CYP2E1—Metabolism—AKT1—melanoma	2.11e-06	1.8e-05	CbGpPWpGaD
Cimetidine—CYP3A5—Metabolism—AKT1—melanoma	2.11e-06	1.79e-05	CbGpPWpGaD
Cimetidine—CYP2C19—Metabolism—PIK3CA—melanoma	2e-06	1.7e-05	CbGpPWpGaD
Cimetidine—CYP3A4—Metabolism—PIK3CB—melanoma	1.97e-06	1.67e-05	CbGpPWpGaD
Cimetidine—CYP3A4—Metabolism—PTGS2—melanoma	1.95e-06	1.66e-05	CbGpPWpGaD
Cimetidine—ABCB1—Metabolism—PIK3CA—melanoma	1.95e-06	1.66e-05	CbGpPWpGaD
Cimetidine—CYP2D6—Metabolism—PIK3CA—melanoma	1.84e-06	1.56e-05	CbGpPWpGaD
Cimetidine—CYP2C8—Metabolism—AKT1—melanoma	1.83e-06	1.55e-05	CbGpPWpGaD
Cimetidine—CYP2C9—Metabolism—PIK3CA—melanoma	1.82e-06	1.55e-05	CbGpPWpGaD
Cimetidine—CYP3A4—Metabolism—PTEN—melanoma	1.7e-06	1.45e-05	CbGpPWpGaD
Cimetidine—CYP2C19—Metabolism—AKT1—melanoma	1.63e-06	1.39e-05	CbGpPWpGaD
Cimetidine—ABCB1—Metabolism—AKT1—melanoma	1.59e-06	1.35e-05	CbGpPWpGaD
Cimetidine—CYP1A2—Metabolism—PIK3CA—melanoma	1.55e-06	1.32e-05	CbGpPWpGaD
Cimetidine—CYP2D6—Metabolism—AKT1—melanoma	1.5e-06	1.28e-05	CbGpPWpGaD
Cimetidine—CYP2C9—Metabolism—AKT1—melanoma	1.49e-06	1.26e-05	CbGpPWpGaD
Cimetidine—CYP1A2—Metabolism—AKT1—melanoma	1.27e-06	1.08e-05	CbGpPWpGaD
Cimetidine—CYP3A4—Metabolism—PIK3CA—melanoma	1.2e-06	1.02e-05	CbGpPWpGaD
Cimetidine—CYP3A4—Metabolism—AKT1—melanoma	9.8e-07	8.34e-06	CbGpPWpGaD
